DDiT4L promotes autophagy and inhibits pathological cardiac hypertrophy in response to stress

Bridget Simonson1, Vinita Subramanya2, Mun Chun Chan1

  • 1Cardiovascular Research Center, Massachusetts General Hospital, Boston, MA 02114, USA.

Science Signaling
|March 2, 2017
PubMed

Insights

DNA damage-inducible transcript 4-like (DDiT4L) protein promotes pathological cardiac hypertrophy by activating autophagy via mTOR signaling. Suppressing DDiT4L or autophagy reversed cardiac dysfunction, suggesting therapeutic potential for heart disease.

Area of Science:

  • Cardiovascular Biology
  • Cellular Stress Response
  • Molecular Cardiology

Background:

  • Physiological cardiac hypertrophy is adaptive, while pathological hypertrophy is maladaptive and precedes heart failure.
  • Pathological cardiac hypertrophy is linked to stimuli like high blood pressure, oxidative stress, and metabolic stress.
  • The role of specific molecular pathways in differentiating these hypertrophy types is crucial.

Purpose of the Study:

  • To investigate the role of DNA damage-inducible transcript 4-like (DDiT4L) in pathological cardiac hypertrophy.
  • To elucidate the signaling mechanisms, including mTORC1 and mTORC2, by which DDiT4L influences cardiac function and autophagy.
  • To explore DDiT4L as a potential therapeutic target for cardiovascular diseases.

Main Methods:

  • Utilized murine models of physiological and pathological cardiac hypertrophy.
  • Investigated DDiT4L expression and localization in cardiomyocytes under stress.
  • Employed cardiac-specific DDiT4L overexpression and genetic suppression of autophagy in mice.
  • Assessed cardiac function, autophagy levels, and mTOR signaling pathway activity.

Main Results:

  • DDiT4L was expressed in pathological but not physiological cardiac hypertrophy models.
  • DDiT4L localized to early endosomes and promoted stress-induced autophagy via mTORC1 inhibition and mTORC2 activation.
  • Cardiac-specific DDiT4L overexpression led to systolic dysfunction and altered mTOR signaling, which were reversible.
  • Genetic suppression of autophagy also reversed cardiac dysfunction in DDiT4L-overexpressing mice.

Conclusions:

  • DDiT4L acts as a key transducer of pathological stress to autophagy through the mTOR signaling pathway in the heart.
  • Targeting DDiT4L or modulating autophagy and mTOR signaling presents a potential therapeutic strategy for cardiovascular diseases.
  • Understanding DDiT4L's role is critical for developing novel treatments for heart failure.

Related Concept Videos

Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.2K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.8K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
588